AJMC® in the Press, March 31, 2023

Frequent Primary Care Visits May Lower Costs for Higher-Risk Commercially Insured Adults

Today, Amgen announced the launch of AmgenNow, a direct-to-patient program offering evolocumab (Repatha) at nearly 60% below the current US list price.

September 30th 2025

Mediterranean Diet Improves Psoriasis Severity, Study Finds

Tory M. Wolff, MBA, discusses his study showing that frequent routine primary care visits may lower costs for higher-risk commercially insured adults.

Listen

The Mediterranean diet largely consists of higher fruit, vegetable, legume, and fish intake. | image credit: sonyakamoz - stock.adobe.com.jpeg

Dr Anders Kolb on Leading Blood Cancer United Into a New Era

A 16-week Mediterranean diet reduced psoriasis severity and improved metabolic health in patients with mild to moderate psoriasis.

September 25th 2025

2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells

Blood Cancer United, formerly Leukemia & Lymphoma Society, aims to enhance awareness and support for blood cancer patients during Blood Cancer Awareness Month.

Listen

Nobel prize | Image Credit: Jean-Luc Flémal - BE - stock.adobe.com

FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years

Three researchers received the 2025 Nobel Prize in Physiology or Medicine for discovering regulatory T cells and the Foxp3 gene, which revealed how the immune system prevents autoimmune disease.

FDA approval | Image Credit: © muh-stock.adobe.com

Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms

Roflumilast cream 0.05% gains FDA approval for young children, offering a safe, effective treatment for mild to moderate atopic dermatitis.

Related Content

Frequent Primary Care Visits May Lower Costs for Higher-Risk Commercially Insured Adults

Today, Amgen announced the launch of AmgenNow, a direct-to-patient program offering evolocumab (Repatha) at nearly 60% below the current US list price.

September 30th 2025

Mediterranean Diet Improves Psoriasis Severity, Study Finds

Tory M. Wolff, MBA, discusses his study showing that frequent routine primary care visits may lower costs for higher-risk commercially insured adults.

Listen

Dr Anders Kolb on Leading Blood Cancer United Into a New Era

A 16-week Mediterranean diet reduced psoriasis severity and improved metabolic health in patients with mild to moderate psoriasis.

September 25th 2025

2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells

Blood Cancer United, formerly Leukemia & Lymphoma Society, aims to enhance awareness and support for blood cancer patients during Blood Cancer Awareness Month.

Listen

FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years

Three researchers received the 2025 Nobel Prize in Physiology or Medicine for discovering regulatory T cells and the Foxp3 gene, which revealed how the immune system prevents autoimmune disease.